However, the literature indicates that dogs with Luminal B HER-2 positive mammary carcinomas have shorter survival times [23,34,35,36,37], emphasizing the need for further research on the role of molecular profiles in mixed tumors. The gene discussed is ERBB2; the disease is breast carcinoma.